Aging and Lung Disease: Clinical Impact and Cellular and Molecular Pathways
衰老与肺部疾病:临床影响以及细胞和分子途径
基本信息
- 批准号:8785180
- 负责人:
- 金额:$ 2.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2015-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute DiseaseAcute Lung InjuryAdult Respiratory Distress SyndromeAffectAgeAgingAmericanAreaAsthmaAwardBiological AgingBiologyBiology of AgingCell AgingCellular biologyCensusesChestChronic DiseaseChronic Obstructive Airway DiseaseChronic lung diseaseClinicalCommunitiesDataDevelopmentDiagnosisDisciplineElderlyEnsureEnvironmentEventFacultyFundingFutureGeneticGenetic MedicineGeriatricsGerman populationGermanyGoalsHamman-Rich syndromeHealth ProfessionalHealthcareImmuneImpairmentIncidenceInfectionInstitutionInternationalInvestigationLearningLinkLungLung diseasesMalignant NeoplasmsMedicalMedicineMitochondriaMolecularNon-Insulin-Dependent Diabetes MellitusOlder PopulationOrganOutcomeParticipantPathogenesisPathologyPathway interactionsPatientsPhysiciansPopulationPostdoctoral FellowPredispositionPrevalencePreventionPublic HealthPulmonary FibrosisPulmonologyRequest for ApplicationsResearchResearch PersonnelRespiratory SystemRespiratory physiologyScienceScientific Advances and AccomplishmentsScientistSeriesSocietiesStem cellsStudentsTherapeuticTimeTravelUnited States National Institutes of HealthUniversitiesabstractingage relatedaging populationcell agedesignfunctional declineimprovedinnovationinterestinterstitiallung repairmeetingsnervous system disordernovel diagnosticsnovel strategiesnovel therapeuticsplanetary Atmospherepostersprogramspublic health relevanceregenerativerepairedresponsestem cell biologysymposiumtreatment strategy
项目摘要
DESCRIPTION (provided by applicant):
This application requests partial funding for the 2014 Pittsburgh-Munich Lung Conference entitled "Aging and Lung Disease: Clinical Impact, and Cellular and Molecular Pathways." The conference will be held on October 23-24, 2014, at the University Club in Pittsburgh, PA. Expected attendance is 300-400 and will include basic scientists, physician-scientists, clinicians,
and other health professionals. Speakers and attendees will be junior and senior investigators as well as trainees specializing in a wide range of scientific disciplines (cell biology, genetics,
medicine, pulmonary, geriatrics, public health). This Conference represents the 13th annual Pittsburgh Lung meeting with a unique blend of cutting-edge science in the field of pulmonary diseases and aging. The specific topics to be covered in this conference include: (1) "OMICS" of aging; (2) Age, genetics and lung diseases; (3) Molecular drivers of cell aging, and their impact in the respiratory system; (4) Mitochondria and aging; (5) Lung diseases and aging; (6) Aging stem cells and lung repair. We believe that this meeting is unique, timely, and highly important because it will bring together recognized experts within the aging-cell biology, genetics, pulmonary, geriatrics communities in a venue designed to both disseminate new information and to promote the interaction of established and junior investigators. This meeting will provide a framework for novel approaches and directions for future age-related lung diseases research.
描述(由申请人提供):
这项申请要求为2014年匹兹堡-慕尼黑肺病会议提供部分资金,题为“衰老与肺部疾病:临床影响以及细胞和分子途径”。大会将于2014年10月23日至24日在宾夕法尼亚州匹兹堡的大学俱乐部举行。预计出席人数为300-400人,包括基础科学家、内科科学家、临床医生、
和其他健康专业人士。演讲者和与会者将是初级和高级调查人员以及专门从事广泛科学学科(细胞生物学、遗传学、
医学、肺科、老年病学、公共卫生)。本次会议代表着第13届匹兹堡肺病年会,将肺部疾病和老龄化领域的尖端科学独特地融合在一起。本次会议的具体议题包括:(1)衰老的“OMICS”;(2)年龄、遗传学和肺部疾病;(3)细胞衰老的分子驱动因素及其对呼吸系统的影响;(4)线粒体与衰老;(5)肺部疾病与衰老;(6)衰老干细胞与肺修复。我们相信,这次会议是独特的、及时的和非常重要的,因为它将把衰老细胞生物学、遗传学、肺病学、老年病学社区中公认的专家聚集在一个旨在传播新信息和促进现有研究人员和初级研究人员互动的场所。这次会议将为未来与年龄相关的肺部疾病研究提供新的方法和方向的框架。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ana Lucia Mora其他文献
The first field trials of the chemically synthesized malaria vaccine SPf66: safety, immunogenicity and protectivity.
化学合成疟疾疫苗 SPf66 的首次现场试验:安全性、免疫原性和保护性。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:5.5
- 作者:
R. Amador;Alberto Moreno;V. Valero;Luis Angel Murillo;Ana Lucia Mora;M. Rojas;Claudia L. Rocha;Margarita Salcedo;Fanny Guzmán;Fabiola Espejo;Francisco Nũnez;Manuel E. Patarroyo - 通讯作者:
Manuel E. Patarroyo
Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia
在哥伦比亚接种 SPf66(一种化学合成疫苗)来预防恶性疟原虫疟疾
- DOI:
- 发表时间:
1993 - 期刊:
- 影响因子:0
- 作者:
M. V. Valero;L. R. Amador;C. Galindo;J. Figueroa;M. Belló;Luis Angel Murillo;Ana Lucia Mora;G. Patarroyo;Claudia L. Rocha;Mauricio Rojas;J. J. Aponte;L. E. Sarmiento;D. Lozada;C. Coronell;N. M. Ortega;Jaiver E. Rosas;M. E. Patarroyo;P. Alonso - 通讯作者:
P. Alonso
ER-Stress Drives the Increased Susceptibility To Lung Fibrosis in Aging Individuals Through a ROS-Mediated Mechanism
- DOI:
10.1016/j.freeradbiomed.2011.10.421 - 发表时间:
2011-11-01 - 期刊:
- 影响因子:
- 作者:
Marta Bueno;Patrick Joseph Pagano;Mauricio Rojas;Ana Lucia Mora - 通讯作者:
Ana Lucia Mora
Ana Lucia Mora的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ana Lucia Mora', 18)}}的其他基金
Type II Alveolar Redox Control in Fibrogenesis and Resolution
纤维发生和分解中的 II 型肺泡氧化还原控制
- 批准号:
10392756 - 财政年份:2020
- 资助金额:
$ 2.57万 - 项目类别:
Type II Alveolar Redox Control in Fibrogenesis and Resolution
纤维发生和分解中的 II 型肺泡氧化还原控制
- 批准号:
10539344 - 财政年份:2020
- 资助金额:
$ 2.57万 - 项目类别:
Type II Alveolar Redox Control in Fibrogenesis and Resolution
纤维发生和分解中的 II 型肺泡氧化还原控制
- 批准号:
10307623 - 财政年份:2020
- 资助金额:
$ 2.57万 - 项目类别:
Type II Alveolar Redox Control in Fibrogenesis and Resolution
纤维发生和分解中的 II 型肺泡氧化还原控制
- 批准号:
10063554 - 财政年份:2019
- 资助金额:
$ 2.57万 - 项目类别:
Signaling mechanisms by which mitochondria regulates fibrosis in the lung
线粒体调节肺纤维化的信号机制
- 批准号:
9233787 - 财政年份:2016
- 资助金额:
$ 2.57万 - 项目类别:
Signaling mechanisms by which mitochondria regulates fibrosis in the lung
线粒体调节肺纤维化的信号机制
- 批准号:
9079520 - 财政年份:2016
- 资助金额:
$ 2.57万 - 项目类别:
相似海外基金
Improving Acute Disease Management for Patients with Alzheimer's Disease and Related Dementias
改善阿尔茨海默病和相关痴呆症患者的急性疾病管理
- 批准号:
10712647 - 财政年份:2001
- 资助金额:
$ 2.57万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
6247642 - 财政年份:1997
- 资助金额:
$ 2.57万 - 项目类别:
INDUCTION OF ACUTE DISEASE IN MACAQUES BY NEF GENE VARIANT OF SIVMAC239
SIVMAC239 的 NEF 基因变体在猕猴中诱导急性疾病
- 批准号:
3718999 - 财政年份:
- 资助金额:
$ 2.57万 - 项目类别:
Neurophysiological alterations in multiple sclerosis patients during acute disease acivity
多发性硬化症患者急性疾病活动期间的神经生理学变化
- 批准号:
465668867 - 财政年份:
- 资助金额:
$ 2.57万 - 项目类别:
Research Grants
SIVMAC 1NEF ALLELE: LYMPHOCYTE ACTIVATION & ACUTE DISEASE IN MACAQUE MONKEYS
SIVMAC 1NEF 等位基因:淋巴细胞激活
- 批准号:
3719026 - 财政年份:
- 资助金额:
$ 2.57万 - 项目类别: